336 related articles for article (PubMed ID: 12659634)
1. Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.
Berry D; Shriver Z; Natke B; Kwan CP; Venkataraman G; Sasisekharan R
Biochem J; 2003 Jul; 373(Pt 1):241-9. PubMed ID: 12659634
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of FGF regulation by cell surface heparan sulfates.
Berry D; Shriver Z; Venkataraman G; Sasisekharan R
Biochem Biophys Res Commun; 2004 Feb; 314(4):994-1000. PubMed ID: 14751231
[TBL] [Abstract][Full Text] [Related]
4. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.
Lundin L; Larsson H; Kreuger J; Kanda S; Lindahl U; Salmivirta M; Claesson-Welsh L
J Biol Chem; 2000 Aug; 275(32):24653-60. PubMed ID: 10816596
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist.
Segev A; Aviezer D; Safran M; Gross Z; Yayon A
Cardiovasc Res; 2002 Jan; 53(1):232-41. PubMed ID: 11744033
[TBL] [Abstract][Full Text] [Related]
7. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells.
Skaletz-Rorowski A; Schmidt A; Breithardt G; Buddecke E
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1063-9. PubMed ID: 8696947
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2 can mediate cell attachment by linking receptors and heparan sulfate proteoglycans on neighboring cells.
Richard C; Liuzzo JP; Moscatelli D
J Biol Chem; 1995 Oct; 270(41):24188-96. PubMed ID: 7592623
[TBL] [Abstract][Full Text] [Related]
10. Ethanol inhibits fibroblast growth factor-induced proliferation of aortic smooth muscle cells.
Ghiselli G; Chen J; Kaou M; Hallak H; Rubin R
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1808-13. PubMed ID: 12907464
[TBL] [Abstract][Full Text] [Related]
11. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of fibroblast growth factor (FGF) receptor-1 mRNA and protein by two molecular forms of basic FGF. Modulation of FGFR-1 mRNA stability.
Estival A; Monzat V; Miquel K; Gaubert F; Hollande E; Korc M; Vaysse N; Clemente F
J Biol Chem; 1996 Mar; 271(10):5663-70. PubMed ID: 8621430
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
Grosskreutz CL; Anand-Apte B; Dupláa C; Quinn TP; Terman BI; Zetter B; D'Amore PA
Microvasc Res; 1999 Sep; 58(2):128-36. PubMed ID: 10458928
[TBL] [Abstract][Full Text] [Related]
14. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
Kinsella MG; Irvin C; Reidy MA; Wight TN
Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
[TBL] [Abstract][Full Text] [Related]
15. Insights into the role of heparan sulphate in fibroblast growth factor signalling.
Harmer NJ
Biochem Soc Trans; 2006 Jun; 34(Pt 3):442-5. PubMed ID: 16709182
[TBL] [Abstract][Full Text] [Related]
16. Proliferation of neointimal smooth muscle cells after arterial injury. Dependence on interactions between fibroblast growth factor receptor-2 and fibroblast growth factor-9.
Agrotis A; Kanellakis P; Kostolias G; Di Vitto G; Wei C; Hannan R; Jennings G; Bobik A
J Biol Chem; 2004 Oct; 279(40):42221-9. PubMed ID: 15292181
[TBL] [Abstract][Full Text] [Related]
17. Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells.
Speir E; Sasse J; Shrivastav S; Casscells W
J Cell Physiol; 1991 May; 147(2):362-73. PubMed ID: 1710230
[TBL] [Abstract][Full Text] [Related]
18. Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition.
Allen BL; Filla MS; Rapraeger AC
J Cell Biol; 2001 Nov; 155(5):845-58. PubMed ID: 11724824
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of disaccharides derived from heparin and evaluation of effects on endothelial cell growth and on binding of heparin to FGF-2.
O'Brien A; Lynch C; O'Boyle KM; Murphy PV
Carbohydr Res; 2004 Oct; 339(14):2343-54. PubMed ID: 15388349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]